Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
26.00
+0.61 (2.40%)
At close: Apr 19, 2024, 4:00 PM
25.90
-0.10 (-0.38%)
After-hours: Apr 19, 2024, 7:59 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Pfizer stock have an average target of 36.88, with a low estimate of 27 and a high estimate of 50. The average target predicts an increase of 41.85% from the current stock price of 26.00.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pfizer stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 3 | 3 | 4 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 11 | 11 | 12 | 10 | 11 | 11 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 17 | 16 | 17 | 16 | 17 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +73.08% | Apr 18, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +73.08% | Apr 15, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +73.08% | Apr 5, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +73.08% | Apr 1, 2024 |
Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 22, 2024 |
Financial Forecast
Revenue This Year
60.60B
from 58.50B
Increased by 3.59%
Revenue Next Year
63.55B
from 60.60B
Increased by 4.88%
EPS This Year
2.22
from 0.37
Increased by 500.29%
EPS Next Year
2.79
from 2.22
Increased by 25.54%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 63.9B | 68.8B | 70.0B | 81.1B | 82.8B |
Avg | 60.6B | 63.6B | 64.1B | 68.8B | 65.5B |
Low | 57.3B | 59.5B | 59.9B | 58.4B | 51.9B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.3% | 13.5% | 10.1% | 26.6% | 20.3% |
Avg | 3.6% | 4.9% | 0.8% | 7.4% | -4.9% |
Low | -2.0% | -1.8% | -5.7% | -8.8% | -24.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.47 | 3.34 | 3.82 | 5.09 | 5.33 |
Avg | 2.22 | 2.79 | 2.92 | 3.85 | 3.70 |
Low | 2.01 | 2.18 | 2.40 | 3.01 | 2.71 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 566.9% | 50.3% | 37.1% | 74.5% | 38.4% |
Avg | 500.3% | 25.5% | 4.6% | 32.1% | -3.9% |
Low | 443.0% | -2.0% | -13.9% | 3.1% | -29.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.